Ex-PDL Exec Can't Dodge MedImmune Subpoena
An ex-PDL BioPharma Inc. executive will have to testify in a patent suit MedImmune LLC brought against PDL over MedImmune's respiratory drugs Synagis and the yet-to-be released motavizumab, having failed to...To view the full article, register now.
Already a subscriber? Click here to view full article